Français | Español

Publications

Examples of ACCP publications.

ACCP provides publications on a range of cervical cancer prevention issues targeted at policymakers, health care providers, program planners, community organizers, researchers, educators, and others.

To request publications or to receive email notices about new publications, send an email to [email protected].


Featured ACCP publications

ACCP summarizes new evidence on cervical cancer screening

ACCP has published a new fact sheet summarizing recent data on cervical cancer screening approaches for low-resource settings. This summary presents evidence published since ACCP's 2009 article (see below) on alternative screening approaches.

New evidence continues to support the feasibility and accuracy of screening technologies that are alternatives to resource-intensive Pap smears. Comprehensive prevention programs that include human papillomavirus (HPV) vaccination of young adolescent girls before exposure to HPV, timely screening with HPV testing or visual inspection for mid-adult women, and appropriate treatment can dramatically reduce cervical cancer mortality.


September 2009 article by ACCP partners

Sherris J, Wittet S, Kleine A, et al. Evidence-Based, Alternative Cervical Cancer Screening Approaches in Low-Resource Settings. International Perspectives on Sexual and Reproductive Health. 2009;35(3)147-152.


New evidence on the impact of cervical cancer screening and treatment using HPV DNA tests, visual inspection, or cytology

This 3-page fact sheet puts new evidence from India into context and provides guidance relating to investment in visual inspection-based screening programs in low-resource settings. The document seeks to help program managers and decision-makers interpret and use the new data.

Ten Key Findings and Recommendations for Effective Cervical Cancer Screening and Treatment Programs

In early 2007, the ACCP partners met to assess newly-analyzed results of key studies in India, South Africa, Peru, and Thailand. These new data spurred the partners to outline ten key findings and recommendations for global policy and practice related to cervical cancer screening and treatment in low-resource settings.

ACCP presents at 2006 XVIII FIGO World Congress of Gynecology and Obstetrics

The ACCP offered several sessions at the 2006 XVIII FIGO World Congress of Gynecology and Obstetrics on the topic of "Cervical Cancer Prevention in Low-Resource Settings: Lessons Learned in Screening, Treatment, and Advocacy." This panel presentation examined the experiences of Alliance for Cervical Cancer Prevention (ACCP) member organizations in the developing world. The following four presentations were given:

Moving from Research to Practice: Expanding Cervical Cancer Prevention Services in Low Resource Settings
Harshad C. Sanghvi, JHPIEGO

Delivering, Safe, Effective and Acceptable Cervical Cancer Prevention Services in Low Resource Settings
J. Bradley, EngenderHealth

ACCP Evidence Base: Implications for Policy and Practice
Dr. R. Sankaranarayanan, International Agency for Research in Cancer (IARC)

Advocating for Existing and New Cervical Cancer Prevention Approaches: Lessons Learned
Dr. Jacqueline Sherris, PATH

 

BBC World Kill or Cure? episode on cervical cancer and the HPV vaccine features the ACCP

BBC World’s third series of Kill Or Cure? provides a look at screening strategies to prevent cervical cancer and the development of a vaccine to protect against the human papillomavirus (HPV), the cause of cervical cancer. The documentary features ACCP projects in Costa Rica and India. First aired on BBC World on Friday, October 7, 2005 as a 30-minute film, you may now view a shortened version online by clicking below. Windows Media Player is required to view (Size: 38.7 Mb).

 

ACCP supplement of International Journal of Gynecology and Obstetrics: "Alliance for Cervical Cancer Prevention: Shifting the Paradigm". (Vol 89, Supplement 2, May 2005)

In a new special supplement of the International Journal of Gynecology and Obstetrics, the ACCP summarizes 5 years of experience in the prevention of cervical cancer in developing countries. Two of the eight articles report the results of research on innovative approaches to screening and treatment in low-resource settings. Three articles highlight the Alliance 's findings from various projects exploring programmatic issues of service delivery, clinical training, and community involvement. One article underscores the critical role of advocacy efforts at the international, regional, national, and local levels for raising awareness and gaining support for prevention program policy. The final paper analyzes the implications of the ACCP's efforts and the current status of cervical cancer prevention worldwide.

 

Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers. ACCP (2004).

Due to this publication's large file size, it is divided here into 6 Portable Document Format (PDF) files for downloading, or it can be downloaded as one, large PDF:


French


Spanish

Special Features

ACCP supplement of International Journal of Gynecology and Obstetrics: "Alliance for Cervical Cancer Prevention: Shifting the Paradigm". (Vol 89, Supplement 2, May 2005)

The eight-article supplement is currently available for free; below are links to each article:

 

Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers. ACCP (2004).

Due to this publication's large file size, it is divided here into 6 Portable Document Format (PDF) files for downloading, or it can be downloaded as one, large PDF:

 

Women's Stories, Women's Lives: Experiences with Cervical Screening and Treatment. ACCP. (2004).

 

Preventing Cervical Cancer Worldwide, a joint report, with an accompanying policy brief, produced by the Population Reference Bureau (PRB) and ACCP (2004).

Fact Sheets

Conclusions From ACCP Clinical Research in Developing Countries
[ACCP: Cervical Cancer Fact Sheet] (October 2004).

Natural History of Cervical Cancer: Even Infrequent Screening of Older Women Saves Lives
[ACCP: Cervical Cancer Fact Sheet] (April 2003).

Palliative Care: Supporting Women with Advanced Cancer
[ACCP: Cervical Cancer Fact Sheet] (April 2003).

HPV Testing: Promise and Challenges
[ACCP: Cervical Cancer Fact Sheet] (March 2003).

Key Steps for Meeting Women's Needs
[ACCP: Cervical Cancer Fact Sheet] (October 2002).

Pap Smears: An Important But Imperfect Method
[ACCP: Cervical Cancer Fact Sheet] (October 2002).

Visual Screening Approaches: Promising Alternative Screening Strategies.
[ACCP: Cervical Cancer Fact Sheet] (October 2002).

Questions Frequently Asked by Women
[ACCP: Cervical Cancer Fact Sheet] (May 2003).

Treating Precancerous Cervical Lesions
[ACCP: Cervical Cancer Fact Sheet] (May 2003).

Risk Factors for Cervical Cancer: Evidence to Date                                                                                  [ACCP: Cervical Cancer Fact Sheet] July 2004.

 

Cervical Cancer Prevention Issues in Depth Series

Effectiveness, Safety and Acceptability of Cryotherapy: A Systematic Literature Review
Cervical Cancer Prevention Issues in Depth No.1. ACCP. (2003).

 

ACCP Strategies for Supporting Women With Cervical Cancer. Cervical Cancer Prevention Issues in Depth No.2. ACCP. (2004).

 

The Case for Investing in Cervical Cancer Prevention, Cervical Cancer Prevention Issues in Depth No.3 ACCP. (2004)

Improving Screening Coverage Rates of Cervical Cancer Prevention Programs: A Focus on Communities, Cervical Cancer Prevention Issues in Depth No.4. ACCP. (2004)

Presentations

Materials you can use and adapt for your own presentation needs, available in both PowerPoint and PDF with notes to accompany the slides.

Developing Cervical Cancer Screening Programs that Meet Women's Needs.
(March 2003).

Women's Frequently Asked Questions About Cervical Cancer Screening: Helping Health Care Providers Anticipate and Answer Common Questions.
(March 2003).

The Pap Test: Evidence to date

Visual inspection with acetic acid (VIA): Evidence to date

Visual inspection with Lugol's iodine (VILI): Evidence to date

Researching new prevention approaches for cervical cancer: Methodological guidelines

Planning Guides

Palliative Care for Women with Cervical Cancer: A Field Manual. PATH, EngenderHealth (2003).

 

Palliative Care for Women With Cervical Cancer: A Kenya Field Manual. PATH (2004).

 

Program Capacity Assessment Tool: Integrating Cervical Cancer Prevention into Reproductive Health Services
PATH. Reproductive Health Reports #4. PATH (July 2001).

Planning Appropriate Cervical Cancer Prevention Programs, 2nd Edition
Herdman C, Sherris J. Seattle, Washington: PATH (2000).

Training Materials

How Can We Prevent Cervical Cancer? A Guide for Community Facilitators. PATH, PAHO, and the Peru Ministry of Health. (2002).

 

Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginner’s Manual
Sellors JW, Sankaranarayanan R. Lyon, France: IARC (2003). Non-Serial Publication ISBN 92 832 0412, I.A.R.C. Press. Available for purchase online for US$15 at: www.iarc.fr/pageroot/PUBLICATIONS/howtoorder.pdf.

Men and Women Working Together to Prevent Cervical Cancer: Training Modules for Men Facilitator’s Manual
EngenderHealth: New York (2003). English and Spanish PDFs forthcoming.

Technical Reports

 

Outcomes Research Study on Cervical Cancer Prevention and Treatment: Results from Ghana
Harshad Sanghvi, Marya Plotkin, Amanda Adu-Amankwa, Sylvia Deganus, Sydney Adadevoh, Elaine Charurat, Amy Kleine, Ricky Lu, John McGrath. JHPIEGO (2008).

Scale-Up, Performance and Quality in the Cervical Cancer Prevention Program in Thailand: Results from the Outcomes Research Study
Harshad Sanghvi, Elaine Charurat, Khunying Kobchitt Limpaphayom, Marya Plotkin, Amy Kleine, Ricky Lu. JHPIEGO (2008).

Western Kenya Cervical Cancer Prevention Project (WKCCPP) Final Report.                                   PATH, Kenya Ministry of Health, Maendeleo ya Wanawake Organization, and the Kenya Cancer Society. (December 2004).

A Qualitative Evaluation of the Acceptability and Feasibility of a Single-Visit Approach to Cervical Cancer Prevention in Ghana                                                                                                                                      Corneli A, Kleine A, Salvador-Davila G, Gaffikin L, Lewis R, Adu-Amankwah A. JHPIEGO (2004).

Safety, Acceptability, and Feasibility of a Single-Visit Approach to Cervical Cancer Prevention: Results from a Demonstration Project in Rural Thailand.
Gaffikin L, Lauterbach M, Emerson M, Cervicare Thailand Group. JHPIEGO (2003).

A Qualitative Evaluation of the Acceptability and Feasibility of a Single-Visit Approach to Cervical Cancer Prevention; Roi-et Province, Thailand.
Corneli A, Gaffikin A, Baldwin L. JHPIEGO (2003).

Visual Inspection of the Uterine Cervix with Acetic Acid (VIA): A Critical Review and Selected Articles.                                                                                                                                                                      Robles S, Ferreccio C, Gage J. Pan American Health Organization (2003).

Women’s Perspectives on Cervical Cancer Screening and Treatment: Participatory Action Research in Khayelitsha
EngenderHealth: South Africa (2002). English and Spanish PDFs forthcoming.

Evaluation of the Situation of Cervical Cancer in Bolivia: Background Document
Bolivia Ministry of Health, EngenderHealth, Pan American Health Organization: La Paz, Bolivia (2003). English and Spanish PDFs forthcoming.

Cervical Cancer Prevention and Treatment Services in Bolivia: A Strategic Assessment
Bolivia Ministry of Health, EngenderHealth, Pan American Health

HPV-DNA Testing: Technical and Programmatic Issues for Cervical Cancer Prevention in Low-Resource Settings
Malloy C, Sherris J, Herdman C. Seattle, Washington: PATH (2000).

HPV Vaccines: Promise and Challenges
Kols A, Sherris J. Seattle, Washington: PATH (2000).

Qualitative Assessment of the Knowledge, Attitudes, and Practices Regarding Cervical Cancer Among Selected Women and Providers in Nayarit State, Mexico
PATH. Technical Report submitted to PAHO (November 1998).

Assessing Health Need/Community Demand for Cervical Cancer Control: Results from a Study in Kenya
PATH. Reproductive Health Reports 1 (December 1996).
Executive summary available online at http://www.path.org/resources/cxca_study_kenya.htm

Cervical Dysplasia Treatment in Developing Countries: A Situation Analysis.
Bishop A, Sherris J, Tsu V. Seattle, Washington: PATH (1995).

Conference Proceedings and Presentations

The ACCP offered several sessions at the 2006 XVIII FIGO World Congress of Gynecology and Obstetrics on the topic of "Cervical Cancer Prevention in Low-Resource Settings: Lessons Learned in Screening, Treatment, and Advocacy." This panel presentation examined the experiences of Alliance for Cervical Cancer Prevention (ACCP) member organizations in the developing world. The following four presentations were given:

Moving from Research to Practice: Expanding Cervical Cancer Prevention Services in Low Resource Settings
Harshad C. Sanghvi, JHPIEGO

Delivering, Safe, Effective and Acceptable Cervical Cancer Prevention Services in Low Resource Settings
J. Bradley, EngenderHealth

ACCP Evidence Base: Implications for Policy and Practice
Dr. R. Sankaranarayanan, International Agency for Research in Cancer (IARC)

Advocating for Existing and New Cervical Cancer Prevention Approaches: Lessons Learned
Dr. Jacqueline Sherris, PATH

Cervical Cancer Prevention: Report on Conference Proceedings, Durres, Albania, March 2004           Coffey P. (PATH). The Open Society Institute Network Public Health Program, PATH, The Open Society Foundation for Albania, and The Open Society Fund—Lithuania (2004).

The ACCP held a session at the 2003 XVII FIGO World Congress of Gynecology and Obstetrics highlighting four years of the Alliance's work in identifying, promoting, and implementing strategies for preventing cervical cancer in developing countries. The following four presentations were given during this session:

Overview of Alliance for Cervical Cancer Prevention (ACCP)
Chairperson, Dr Sylvia Robles MD, PAHO

Screening options for cervical cancer prevention
Dr R Sankaranarayanan MD, IARC

Treatment with cryotherapy by mid level clinicians in low resource settings.
Dr Paul Blumenthal MD, MPH, JHPIEGO

Approaches for delivery of cervical cancer prevention services
Dr Martha Jacob FRCOG, MPH, EngenderHealth

Summary of Proceedings: Consultative Forum on Cervical Cancer Prevention in Low-Resource Settings.
PATH. (2001).

Prevention and Control of Cervical Cancer in the East and Southern Africa Region
Abwao S, Greene P, Sanghvi H, Tsu V, Winkler J, eds. AVSC, PATH, Pathfinder, JHPIEGO (1998).
Summary of proceedings of regional meeting held in Nairobi, Kenya, March 29 - April 1, 1998.

Alternatives in Cervical Cancer Screening and Treatment in Low-Resource Settings (Highlights)
JHPIEGO. (1997).
Highlights of a workshop on unaided visual inspection and cryotherapy for low-resource settings.

Factors Affecting a Screening Test
Gaffikin, L. In: Alternatives for Cervical Cancer Screening and Treatment in Low-Resource Settings. Workshop proceedings, May 21-22, 1997. Baltimore, Maryland: JHPIEGO. pp 18-19

Zimbabwe Cervical Cancer Screening Study
Gaffikin, L. In: Alternatives for Cervical Cancer Screening and Treatment in Low-Resource Settings. Workshop proceedings, May 21-22, 1997. Baltimore, Maryland: JHPIEGO. pp 52-53 Gaffikin L. et al., eds. Baltimore, Maryland: JHPIEGO. pp. 80-84 (December 1997).

Key Clinical Issues in Treatment of Precancerous Lesions of the Cervix
Blumenthal, P. In: Alternatives for Cervical Cancer Screening and Treatment in Low-Resource Settings. Workshop proceedings, May 21-22, 1997. Baltimore, Maryland: JHPIEGO. pp 65-68.

Cervical Cancer Treatment: Options and Experiences in Low-resource Settings
Sherris J. In: Alternatives for Cervical Cancer Screening and Treatment in Low-resource Settings. Workshop proceedings, May 21-22, 1997. Gaffikin L. et al., eds. Baltimore, Maryland: JHPIEGO. pp. 69-75 (December 1997)

Considerations for Designing a Cervical Cancer Control Program
Sherris J. In: Alternatives for Cervical Cancer Screening and Treatment in Low-resource Settings. Workshop proceedings, May 21-22, 1997.

Training for Visual Inspection: Zimbabwe
Blumenthal, P. In: Alternatives for Cervical Cancer Screening and Treatment in Low-Resource Settings. Workshop proceedings, May 21-22, 1997. Baltimore, Maryland: JHPIEGO. pp 94-97

Visual Inspection of the Cervix as a Screening Option
Blumenthal, P. In: Alternatives for Cervical Cancer Screening and Treatment in Low-Resource Settings. Workshop proceedings, May 21-22, 1997. Baltimore, Maryland: JHPIEGO. pp 32-33

Why Visual Inspection with Acetic Acid?
Blumenthal, P. In: Alternatives for Cervical Cancer Screening and Treatment in Low - Resource Settings. Workshop proceedings, May 21-22, 1997. Baltimore, Maryland: JHPIEGO. pp 16-17

Visual Inspection for Cervical Dysplasia: Preliminary Evaluation Studies in Indonesia (1992-1994)
Tsu V. In: Alternatives for Cervical Cancer Screening and Treatment in Low-resource Settings. Workshop proceedings, May 21-22, 1997. Gaffikin L. et al., eds. Baltimore, Maryland: JHPIEGO. pp. 41-45 (December 1997).

Accuracy of Pap smears: Recent Findings from a Meta-analysis
Gaffikin, L. In: Alternatives for Cervical Cancer Screening and Treatment in Low-Resource Settings. Workshop proceedings, May 21-22, 1997. Baltimore, Maryland: JHPIEGO. pp 24-25.

Journal Articles

2006 ACCP Member Journal Articles

Improving cervical cancer prevention in a developing country.                                                           
Agurto I, Sandoval J, De La Rosa M, Guardado ME. International Journal for Quality in Health Care 2006; 18 (2): 81–86.

Providers’ constructions of the role of women in cervical cancer screening in Bulgaria and Romania.
Todorovaa ILG, Babanb A, Balabanovac D, Panayotovaa Y, Bradley J. Social Science & Medicine. 63 (2006) 776–787.

Direct Comparison of Liquid-Based and Conventional Cytology in a South African Screening Trial.
Taylor S, Kuhn L, Dupree W, Denny L, De Souza M, Wright TC. International Journal of Cancer. 2006; 118:957-62.

Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. 
Myer L, Wright TC, Denny L, Kuhn L. Sexually Transmitted Diseases. 2006 April 11.

Distinguishing the temporal association between women’s intravaginal practices and risk of HIV infection: A prospective study among South African women. 
Myer L, Denny L, De Sousa M, Wright TC, Kuhn L. American Journal of Epidemiology. 2006; 163:552-60.

Worldwide Burden of Gynaecological Cancer: the size of the problem.
Sankaranarayanan R. Ferlay J.  Best Practice & Research Clinical Obstetrics & Gynaecology - Special issue on Screening and the Prevention of Gynaecological Cancer. 2006;20 (2):207-225.

Preliminary report of a gas conditioner to improve operational reliability of cryotherapy in developing countries.
Seamans, Y, Sellors J, Broekhuizen F, Howard M. BioMed Central Women’s Health.  2006;6:2.

2005 ACCP Member Journal Articles

The ACCP published a supplement of theInternational Journal of Gynecology and Obstetrics: "Alliance for Cervical Cancer Prevention: Shifting the Paradigm," including the following eight articles. The articles are available for download under Special Features.

Preventing cervical cancer in low-resource settings: Building a case for the possible.
Pollock AE, Tsu VD. International Journal of Gynaecology and Obstetrics. 2005 May;89 Suppl 2:S1-3.

 A critical assessment of screening methods for cervical neoplasia.
Sankaranarayanan R. Gaffikin L, Jacob M, Sellors J, Robles S. International Journal of Gynaecology and Obstetrics. 2005 May;89 Suppl 2:S4-S12.

 Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings.
Jacob M, Broekhuisen FF, Castro W, Sellors J. International Journal of Gynaecology and Obstetrics, 2005;89:S13-S20.

 Delivering cervical cancer prevention services in low-resource settings.
Bradley J, Barone M, Mahe´ C, Lewis R, Luciani S. International Journal of Gynaecology and Obstetrics. 2005 May;89 Suppl 2:S21-S29.

 Training for Cervical Cancer Prevention Programs in Low-Resource Settings: Focus on visual inspection with acetic acid and cryotherapy.
Blumenthal P, Lauterbach J, Sellors J, Sankaranarayanan R.  International Journal of Gynaecology and Obstetrics. 2005 May;89 Suppl 2:S30-7.

Involving the community in cervical cancer prevention programs.  
Agurto I, Arrossi S, White S, Coffey P, Dzuba I, Bingham A, Bradley J, Lewis R. International Journal of Gynaecology and Obstetrics. 2005 May;89 Suppl 2:S38-45.

Advocating for cervical cancer prevention.
Sherris J, Agurto I, Arrossi S, Dzuba I, Gaffikin L, Herdman C, Limpaphayom K, Luciani S.  International Journal of Gynaecology and Obstetrics. 2005 May;89 Suppl 2:S46-54.

Preventing cervical cancer in low-resource settings: How far have we come and what does the future hold?
Tsu VD, Pollock AE. International Journal of Gynaecology and Obstetrics. 2005 May;89 Suppl 2:S55-59.

Other 2005 ACCP Member Journal Articles

Human papillomavirus testing and screening.
Denny LA and Wright TC. Best practice & research. Clinical Obstetrics & Gynaecology.  2005;19:501-15.

Bacterial vaginosis and susceptibility to HIV infection among South African women: a nested case-control study.
Myer L, Denny L, Telerant R, De Sousa M, Wright TC, Kuhn L. Journal of Infectious Diseases. 2005;192:1372-80.

Screen and Treat Approaches for cervical cancer prevention in low resource settings: Randomized controlled trial.
Denny L, Kuhn L, De Souza M, Pollack A, Dupree W, Wright TC. JAMA. 2005; 294:2173-81.

Estimating HIV hazard rates from cross-sectional HIV prevalence data. 
Wong KF, Tsai WY, Kuhn L.  Statistics in Medicine. 2005, Oct 11.

 Intravaginal practices, bacterial vaginosis and women’s susceptibility to HIV infection: epidemiological evidence and biological mechanisms. 
Myer L, Kuhn L, Stein Z, Wright TC, Denny L. Lancet Infectious Diseases. 2005; 5:786-94.

 The costs of reducing loss to follow-up in South African cervical cancer screening. 
Goldhaber-Fiebet JD, Denny LE, De Souza M, Wright TC Jr, Kuhn L, Goldie SJ. Cost Effectiveness and Resource Allocation. 2005 Nov 15; 3:11.

Cost-effectiveness of cervical cancer screening in India, Kenya, Peru, South Africa and ThailandGoldie SJ, Gaffikin L, Levin C, Mahe C, Goldhaber-Fiebert J, and Wright TC for the ACCP Cost Working Group. New England Journal of Medicine. 2005; 353: 2158-68.

Cervical cancer prevention - a paradigm shift?
Denny L, De Souza M, Kuhn L, Pollack A, Wright TC Jr. Gynecologic oncology. 2005; 99:S12.

The prevention of cervical cancer in developing countries.
Denny L.  BJOG: an International Journal of Obstetrics & Gynaecology. 2005; 112:1204-1212.

Human Papillomavirus Vaccines: what does the future hold for preventing cervical cancer in low resource settings, through immunization programs?
Jacob M, Bradley J and Barone M. Sexually Transmitted Diseases. October 2005;32(10):635-640.

 A Strategic Assessment of Cervical Cancer Prevention and Treatment Services in 3 Districts of Uttar Pradesh, India.
Dabash R; Vajpayee J et al. Reproductive Health. 2005:2;11.

Psychosocial and health system dimensions of cervical screening in Romania
Baban A, Balazasi R, Bradley J et al. Romanian Association of Health Psychology, EngenderHealth and Babes-Bolyai University, Cluj-Napoca, Romania. 2005.

 Cryotherapy treatment for cervical intraepithelial neoplasia: women’s experiences in Peru.
Coffey PS, Bingham A, Winkler J, Bishop A, Sellors J, Lagos G, Moron C. J Midwifery & Women’s Health. 2005;50:335-40.

 Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis.
Ogilvie GS, Patrick DM, Schulzer M, Sellors JW, Petric M, Chambers K, White R, FitzGerald JM. Sex Transm Infect. 2005;81:207-12.

Screening for Cervical and Oral Cancers in India is Feasible and Effective.
Sankaranarayanan R. The National Medical Journal of India. 2005;18(6):281-284.

A cluster randomised controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India.
Sankaranarayanan R. Nene BN, Dinshaw KA, Mahé C, Jayant K, Shastri , Chinoy R, Kelkar R, Budukh AM, Keskar V, Rajeshwarker R, Muwonge R, Kane S, Parkin DM on behalf of the Osmanabad District Cervical Screening Study Group. International Journal of Cancer. 2005;116:617-623.

Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected.
Legood R, Gray AM, Mahé C, Wolstenholme J, Jayant K, Nene DM, Shastri S, Malvi SG, Muwonge R, Budukh A, Sankaranarayanan R. International Journal of Cancer. 2005;117:981-987.

Papillomavirus infection in rural women in southern India.  
Franceschi S, Rajkumar R, Snijders PJ, Arslan A, Mahe C, Plummer M, Sankaranarayanan R. Cherian J, Meijer CJ, Weiderpass E. British Journal of Cancer. 2005 Feb 14;92(3):601-6.

A cluster randomised controlled trial of visual, cytology and HPV screening for cancer of the cervix in rural India.
Sankaranarayanan R. Nene BN, Dinshaw KA, Mahé C, Jayant K, Shastri , Chinoy R, Kelkar R, Budukh AM, Keskar V, Rajeshwarker R, Muwonge R, Kane S, Parkin DM on behalf of the Osmanabad District Cervical Screening Study Group.  International Journal of Cancer. 2005;116(4):617-23.

Concurrent evaluation of visual, cytological and HPV testing screening methods in the early detection of cervical neoplasia in Mumbai, India.                                                                                                 Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, Kane S, Kelkar R, Muwonge R, Mahé C, Ajit D, Sankaranarayanan R .   Bull World Health Organization. March 2005; 83(3): 186-94.

2004 ACCP Member Journal Articles

 

Cervical cancer screening in low resource settings using visual inspection with acetic acid (VIA).

Camacho-Carr K, Sellors JW. J Midwifery & Women’s Health. 2004;49:329-37.

Combining human papillomavirus testing or cervicography with cytology to detect cervical intraepithelial neoplasia.

Howard M, Sellors JW, Lytwyn A, Roth P, Mahony JB. Arch Pathol Lab Med. 2004;128: 1257-62.

Illumination, optics, and clinical performance of an hand-held magnified visual inspection device (AviScope): a comparison with colposcopy.

Sellors JW, Winkler JL, Kreysar DF. J Acquir Immunie Defic Syndr. 2004;35:S1-S7.

Widening the cervical cancer screening net in a South African peri-urban population: Who are the underserved?
Bradley J, Risi L, Denny L. Healthcare for Women International. 2004;25(3):277-241.

Accuracy of visual inspection with acetic acid (VIA): Validation using latent class analysis.     Gaffikin L, McGrath JA, Blumenthal PD. Biometrics . In press.

Perceived barriers and benefits to cervical cancer screening in Latin America.                               Agurto I, Bishop A, Sanchez G, Betancourt Z, Robles S. Preventive Medicine 2004; 39: 91-98.

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 vaccine.           Goldie SJ, Kohli M. Journal of the   National Cancer Institute . 2004;96:604-615.

Optimal cutoff of the hybrid capture II human papillomavirus test for self-collected vaginal, vulvar, and urine specimens in a colposcopy referral population.
Howard M, Sellors J, Kaczorowski J, Lorincz A. Journal of Lower Genital Tract Disease . 2004;8(1): 33-37.

Media interventions to increase cervical screening uptake in South Africa: an evaluation study of effectiveness
Risi L, Bindman J, Campbell O, Imrie J, Everett K, Bradley J, et al. Health Education Research .
2004 Volume 19, Number 4 Pp. 457-468.

Accuracy of HPV testing in primary screening of cervical neoplasia: Results from a multicentre study in India.                                                                                                                                                               Sankaranarayanan R, Chatterji R, Shastri S, Wesley R, Basu P, Mahé C, et al. International Journal   of Cancer. 2004: 112: 341-347.

The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia.                                                                                                                          Sankaranarayanan R, Shastri S, Basu P, Mahé C, Mandal R, Amin G, et al. Cancer Detection and Prevention. 2004;28(5):345-51.

Accuracy of conventional cytology: Results from a multicentre screening in India. Sankaranarayanan R, Somanathan T, Sharma A, Roy C, Shastri S, Mahé C, et al. Journal of   Medical Screening. 2004; 11 (2) 77-84.

Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa.                                                                                                                                                Sankaranarayanan R, Basu P, Rami S, Wesley R, Mahé C, Keita N, et al. International Journal of Cancer. 2004; 110 (6) 907-913.

Initial results from a randomised trial of cervical visual screening in rural South India. Sankaranarayanan R, Rajkumar R, Theresa R, Esmy PO, Mahé C, Bagyalakshmi KR, et al. International Journal of   Cancer . 2004;109(3):461-467.

Cervical cancer as a priority for prevention in different world regions; An evaluation using years of life lost.                                                                                                                                                                       Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang Z. International Journal of Cancer . 2004;109:418-424.

2003 ACCP Member Journal Articles

Confirmation of cervical neoplasia using a hand-held, lighted magnification device.                       Winkler JL, Tsu VD, Bishop A, Scott R, Sellors JW. Int J Gyn and Obst 2003; 81: 35-40.

Incidence and mortality of cervical cancer in Latin America.
Arrossi S, Sankaranarayanan R, Parkin DM. Revista Méxicana de Salud Pública . 2003;45(S3):S306-S314.

Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India.                                                                                                                                                       Basu P, Sankaranarayanan R, Mandal R, Roy C, Das P, Choudhury D, et al. International   Journal of Gynecological Cancer . 2003;13:626-632.

Factors affecting utilization of cervical cancer prevention services in low-resource settings.
Bingham A, Bishop A, Coffey P, Winkler J, Bradley J, Dzuba I, Agurto A. Salud Pública de México . 2003;45(S3):S 408-S416.

Performance of visual inspection with acetic acid for cervical cancer screening: A qualitative summary of evidence to date.
Gaffikin L, Lauterbach M, Blumenthal PD. Obstetrics and Gynecological Survey . 2003;58(8): 543-550.

Risk factors as the basis for triage in low-resource cervical cancer screening programs.
Gaffikin L, Ahmed S, Chen YQ, McGrath JM, Blumenthal PD. International Journal of Gynecological Obstetrics . 2003;80(1):41-47.  

Public health policy and cost-effectiveness analysis.                                                                                     Goldie SJ. Chapter 15. Journal of the National Cancer Institute. Monograph. 2003;(31):102-110.

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.                                                                              Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. International Journal of Cancer . 2003;106(6):896-904.

Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: A demonstration project.
Royal Thai College of Obstetricians and Gynecologists (RTCOG)/JHPIEGO Cervical Cancer Prevention Project. The Lancet . 2003;361(9360):814-820.

Early detection of cervical cancer by visual inspection methods: A summary of completed and on-going studies in India.                                                                                                                                Sankaranarayanan R, Nene BM, Dinshaw K, Rajkumar R, Shastri S, Wesley R, et al. Salud Pública de México . 2003;45(S3);S399-407.

Determinants of participation of women in a cervical cancer visual screening trial in rural south India.                                                                                                                                                 Sankaranarayanan R, Rajkumar R, Arrossi S, Rajapadian T, Esmy PO, Mahé C, et al. Cancer Detection and Prevention . 2003;27:457-465.

Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India.                                                                                                            Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, et al. International Journal of   Cancer . 2003;106(3):404-408.

Screening and management of precancerous lesions to prevent cervical cancer in low-resource settings.
Sellors J, Lewis K, Kidula N, Muhombe K, Tsu V, Herdman C. Asian Pacific Journal of Cancer Prevention . 2003;4(3):277-280.

Population-based survival for cervical cancer in Singapore, 1968-1992.                                                   Wang H, Chia KS, Du W, Lee J, Sankaranarayanan R, Sankila R, et al. American Journal of Obstetrics and Gynecology. 2003;188:324-29.

Cervical cancer screening using visualization techniques.                                                                        Wright T. Chapter 10. Journal of the National Cancer Institute. Monograph . 2003;(31):66-71.

See ACCP Member Journal Articles prior to 2003 (1995-2002)

 

This page displays best in a browser that supports current web standards, but all content is accessible via any web device.